HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 33 filers reported holding HORIZON PHARMA INVT LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,323,000 | – | 2,500,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 99,100,000 | $94,914,000 | 3.33% |
| Lion Point Capital, LP | 16,000,000 | $15,312,000 | 1.38% |
| SYMPHONY ASSET MANAGEMENT LLC | 5,000,000 | $4,804,000 | 0.96% |
| LINDEN ADVISORS LP | 32,106,000 | $30,888,000 | 0.95% |
| OAKTREE CAPITAL MANAGEMENT LP | 46,262,000 | $44,449,000 | 0.62% |
| Nicholas Investment Partners, LP | 8,635,000 | $8,264,000 | 0.58% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,785,000 | $16,100,000 | 0.34% |
| CANYON CAPITAL ADVISORS LLC | 30,000,000 | $28,712,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,250,000 | $3,110,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,278,000 | $6,031,000 | 0.17% |